Related Experiment Video

Updated: Apr 27, 2026

Translational Orthotopic Models of Glioblastoma Multiforme

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

IGF-II-secreting pelvic tumor presenting with neuropsychiatric symptoms

Divya Dahiya¹, Sanjay Bhadada², Uma Nahar³

¹Department of Surgery, PGIMER, Chandigarh, India dahiyadivya30@gmail.com.

Journal of Surgical Case Reports

|June 27, 2014

Abstract:

A 48-year-male presented with a gradually increasing lump in the abdomen, which was confirmed on investigations as a pelvic tumor. He developed frequent episodes of hypoglycemia and neuropsychiatric symptoms while awaiting surgery. During episodes of hypoglycemia, his serum C-peptide and insulin levels were negligible and the insulin-like growth factor (IGF)-II to IGF-I ratio was >10. He successfully underwent an en bloc excision of the tumor. Histopathology revealed a solitary fibrous tumor.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Related Concept Videos

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Cushing Syndrome I: Introduction

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...

Articles linked to this work by shared authors, journal, and citation graph.

Clinicopathological predictors of radioiodine response in differentiated high-grade thyroid carcinoma.

Annals of diagnostic pathology·2026

Early-onset plasma cell-rich acute cellular rejection following liver transplantation in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome: a case report.

Clinical transplantation and research·2026

ConLymphNet: A Generalizable Region-Constrained Deep Learning Architecture for Precise Abdominal Lymph Node Segmentation Across Cancer Types.

JCO clinical cancer informatics·2026

Pulse pressure variation-guided versus low central venous pressure-guided fluid management during elective open hepatectomy: a randomized non-inferiority trial.

BMC anesthesiology·2026

Giant Masses in a Non-Cirrhotic Liver: All That Look Epithelial Are Not Carcinoma.

Cureus·2026

In silico and in vitro antibacterial investigation of Origanum majorana L. leaves extract against gram-positive and gram-negative bacteria.

In silico pharmacology·2026

See all related articles